Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type

R. Takenaka, Hiroyuki Okada, J. Kato, C. Makidono, S. Hori, Yoshiro Kawahara, M. Miyoshi, E. Yumoto, A. Imagawa, T. Toyokawa, K. Sakaguchi, Y. Shiratori

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

Background: Although Helicobacter pylori infection is closely associated with gastric cancer development, follow-up studies after H. pylori eradication are still scarce. Aim: To clarify the cancer preventive effect of H. pylori eradication, with special attention to differences in effect according to histology. Methods: Patients who underwent H. pylori eradication therapy and were followed-up endoscopically for at least 1 year were analysed. The incidence of gastric cancer and factors associated with cancer development were investigated. Results: A total of 1807 patients were enrolled. Six of 1519 H. pylori eradicated and five of 288 persistent subjects developed gastric cancer. Four of the eradicated subjects developed the intestinal type and two the diffuse type, while four of the persistent subjects developed the intestinal type and one the diffuse type. Kaplan-Meier analysis indicated a significantly lower incidence in eradicated patients than in persistent patients. The incidence of intestinal type was significantly lower than in eradicated patients, while the diffuse type could not be evaluated because of the low incidence. Conclusions: Helicobacter pylori-eradicated patients had a reduced incidence of gastric cancer compared with H. pylori-persistent patients, particularly the intestinal type, suggesting that H. pylori is strongly associated with intestinal-type gastric cancer.

Original languageEnglish
Pages (from-to)805-812
Number of pages8
JournalAlimentary Pharmacology and Therapeutics
Volume25
Issue number7
DOIs
Publication statusPublished - Apr 2007

Fingerprint

Helicobacter pylori
Stomach Neoplasms
Incidence
Intestinal Neoplasms
Kaplan-Meier Estimate
Helicobacter Infections
Histology
Neoplasms

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type. / Takenaka, R.; Okada, Hiroyuki; Kato, J.; Makidono, C.; Hori, S.; Kawahara, Yoshiro; Miyoshi, M.; Yumoto, E.; Imagawa, A.; Toyokawa, T.; Sakaguchi, K.; Shiratori, Y.

In: Alimentary Pharmacology and Therapeutics, Vol. 25, No. 7, 04.2007, p. 805-812.

Research output: Contribution to journalArticle

Takenaka, R, Okada, H, Kato, J, Makidono, C, Hori, S, Kawahara, Y, Miyoshi, M, Yumoto, E, Imagawa, A, Toyokawa, T, Sakaguchi, K & Shiratori, Y 2007, 'Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type', Alimentary Pharmacology and Therapeutics, vol. 25, no. 7, pp. 805-812. https://doi.org/10.1111/j.1365-2036.2007.03268.x
Takenaka, R. ; Okada, Hiroyuki ; Kato, J. ; Makidono, C. ; Hori, S. ; Kawahara, Yoshiro ; Miyoshi, M. ; Yumoto, E. ; Imagawa, A. ; Toyokawa, T. ; Sakaguchi, K. ; Shiratori, Y. / Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type. In: Alimentary Pharmacology and Therapeutics. 2007 ; Vol. 25, No. 7. pp. 805-812.
@article{bb198c9d302c4fe48a20b6d4b241e755,
title = "Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type",
abstract = "Background: Although Helicobacter pylori infection is closely associated with gastric cancer development, follow-up studies after H. pylori eradication are still scarce. Aim: To clarify the cancer preventive effect of H. pylori eradication, with special attention to differences in effect according to histology. Methods: Patients who underwent H. pylori eradication therapy and were followed-up endoscopically for at least 1 year were analysed. The incidence of gastric cancer and factors associated with cancer development were investigated. Results: A total of 1807 patients were enrolled. Six of 1519 H. pylori eradicated and five of 288 persistent subjects developed gastric cancer. Four of the eradicated subjects developed the intestinal type and two the diffuse type, while four of the persistent subjects developed the intestinal type and one the diffuse type. Kaplan-Meier analysis indicated a significantly lower incidence in eradicated patients than in persistent patients. The incidence of intestinal type was significantly lower than in eradicated patients, while the diffuse type could not be evaluated because of the low incidence. Conclusions: Helicobacter pylori-eradicated patients had a reduced incidence of gastric cancer compared with H. pylori-persistent patients, particularly the intestinal type, suggesting that H. pylori is strongly associated with intestinal-type gastric cancer.",
author = "R. Takenaka and Hiroyuki Okada and J. Kato and C. Makidono and S. Hori and Yoshiro Kawahara and M. Miyoshi and E. Yumoto and A. Imagawa and T. Toyokawa and K. Sakaguchi and Y. Shiratori",
year = "2007",
month = "4",
doi = "10.1111/j.1365-2036.2007.03268.x",
language = "English",
volume = "25",
pages = "805--812",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type

AU - Takenaka, R.

AU - Okada, Hiroyuki

AU - Kato, J.

AU - Makidono, C.

AU - Hori, S.

AU - Kawahara, Yoshiro

AU - Miyoshi, M.

AU - Yumoto, E.

AU - Imagawa, A.

AU - Toyokawa, T.

AU - Sakaguchi, K.

AU - Shiratori, Y.

PY - 2007/4

Y1 - 2007/4

N2 - Background: Although Helicobacter pylori infection is closely associated with gastric cancer development, follow-up studies after H. pylori eradication are still scarce. Aim: To clarify the cancer preventive effect of H. pylori eradication, with special attention to differences in effect according to histology. Methods: Patients who underwent H. pylori eradication therapy and were followed-up endoscopically for at least 1 year were analysed. The incidence of gastric cancer and factors associated with cancer development were investigated. Results: A total of 1807 patients were enrolled. Six of 1519 H. pylori eradicated and five of 288 persistent subjects developed gastric cancer. Four of the eradicated subjects developed the intestinal type and two the diffuse type, while four of the persistent subjects developed the intestinal type and one the diffuse type. Kaplan-Meier analysis indicated a significantly lower incidence in eradicated patients than in persistent patients. The incidence of intestinal type was significantly lower than in eradicated patients, while the diffuse type could not be evaluated because of the low incidence. Conclusions: Helicobacter pylori-eradicated patients had a reduced incidence of gastric cancer compared with H. pylori-persistent patients, particularly the intestinal type, suggesting that H. pylori is strongly associated with intestinal-type gastric cancer.

AB - Background: Although Helicobacter pylori infection is closely associated with gastric cancer development, follow-up studies after H. pylori eradication are still scarce. Aim: To clarify the cancer preventive effect of H. pylori eradication, with special attention to differences in effect according to histology. Methods: Patients who underwent H. pylori eradication therapy and were followed-up endoscopically for at least 1 year were analysed. The incidence of gastric cancer and factors associated with cancer development were investigated. Results: A total of 1807 patients were enrolled. Six of 1519 H. pylori eradicated and five of 288 persistent subjects developed gastric cancer. Four of the eradicated subjects developed the intestinal type and two the diffuse type, while four of the persistent subjects developed the intestinal type and one the diffuse type. Kaplan-Meier analysis indicated a significantly lower incidence in eradicated patients than in persistent patients. The incidence of intestinal type was significantly lower than in eradicated patients, while the diffuse type could not be evaluated because of the low incidence. Conclusions: Helicobacter pylori-eradicated patients had a reduced incidence of gastric cancer compared with H. pylori-persistent patients, particularly the intestinal type, suggesting that H. pylori is strongly associated with intestinal-type gastric cancer.

UR - http://www.scopus.com/inward/record.url?scp=33947224229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947224229&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2036.2007.03268.x

DO - 10.1111/j.1365-2036.2007.03268.x

M3 - Article

C2 - 17373919

AN - SCOPUS:33947224229

VL - 25

SP - 805

EP - 812

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

SN - 0269-2813

IS - 7

ER -